Knight Therapeutics Inc. (FRA:04K)
3.700
0.00 (0.00%)
At close: Dec 5, 2025
Knight Therapeutics Employees
Knight Therapeutics had 745 employees as of December 31, 2024. The number of employees increased by 20 or 2.76% compared to the previous year.
Employees
745
Change (1Y)
20
Growth (1Y)
2.76%
Revenue / Employee
€339,905
Profits / Employee
€2,869
Market Cap
372.47M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| SAP SE | 109,121 |
| Siemens Aktiengesellschaft | 318,000 |
| Allianz SE | 156,626 |
| Deutsche Telekom AG | 198,194 |
| Siemens Energy AG | 103,000 |
| Rheinmetall AG | 28,539 |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Knight Therapeutics News
- 4 weeks ago - Knight Therapeutics Inc. (GUD:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Knight Therapeutics Inc (KHTRF) Q3 2025 Earnings Call Highlights: Record Revenues and Strategic ... - GuruFocus
- 4 weeks ago - Q3 2025 Knight Therapeutics Inc Earnings Call Transcript - GuruFocus
- 4 weeks ago - Knight Therapeutics reports Q3 results - Seeking Alpha
- 4 weeks ago - Knight Therapeutics Reports Third Quarter 2025 Results - GlobeNewsWire
- 5 weeks ago - Knight Announces Closing of US$100 Million Revolving Credit Facility - GlobeNewsWire
- 5 weeks ago - Knight Therapeutics announces launch of JORNAY PM - Seeking Alpha
- 5 weeks ago - Notice of Knight Therapeutics' Third Quarter 2025 Results Conference Call - GlobeNewsWire